Drug Type Small molecule drug |
Synonyms VVZ-N2, VVZ-N2-1 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Pain | Preclinical | United States | 01 May 2025 | |
| Unspecified drug dependence | Preclinical | United States | 01 May 2025 | |
| Anxiety Disorders | Preclinical | United States | 02 Mar 2022 | |
| Depressive Disorder | Preclinical | United States | 02 Mar 2022 | |
| psychological symptoms behavior compulsive behavior addiction | Preclinical | United States | 02 Mar 2022 |





